These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29593743)

  • 1. Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity.
    Van Kaer L; Wu L
    Front Immunol; 2018; 9():519. PubMed ID: 29593743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.
    Van Kaer L; Parekh VV; Wu L
    Immunotherapy; 2011 Jan; 3(1):59-75. PubMed ID: 21174558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of iNKT cells in the immunopathology of systemic lupus erythematosus.
    Gabriel L; Morley BJ; Rogers NJ
    Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoregulation by iNKT cells].
    Miyake S
    Yakugaku Zasshi; 2009 Jun; 129(6):649-53. PubMed ID: 19483407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of regulation of autoimmunity by iNKT cells.
    Novak J; Lehuen A
    Cytokine; 2011 Mar; 53(3):263-70. PubMed ID: 21185200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications.
    Hebbandi Nanjundappa R; Shao K; Krishnamurthy P; Gershwin ME; Leung PSC; Sokke Umeshappa C
    Autoimmun Rev; 2024 Feb; 23(2):103485. PubMed ID: 38040101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
    Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
    Front Immunol; 2018; 9():1266. PubMed ID: 29928278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer T cells and autoimmune disease.
    Wu L; Van Kaer L
    Curr Mol Med; 2009 Feb; 9(1):4-14. PubMed ID: 19199937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases?
    Caielli S; Sorini C; Falcone M
    Autoimmunity; 2011 Feb; 44(1):11-22. PubMed ID: 20672910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
    Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
    Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant natural killer T cells and their ligands: focus on multiple sclerosis.
    O'Keeffe J; Podbielska M; Hogan EL
    Immunology; 2015 Aug; 145(4):468-75. PubMed ID: 25976210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune regulation by invariant NKT cells in autoimmunity.
    Ronchi F; Falcone M
    Front Biosci; 2008 May; 13():4827-37. PubMed ID: 18508548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of invariant NKT cells in organ-specific autoimmunity.
    Di Pietro C; Falcone M
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1240-50. PubMed ID: 24896348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunometabolic Activation of Invariant Natural Killer T Cells.
    Ververs FA; Kalkhoven E; Van't Land B; Boes M; Schipper HS
    Front Immunol; 2018; 9():1192. PubMed ID: 29892305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.
    Mars LT; Novak J; Liblau RS; Lehuen A
    Trends Immunol; 2004 Sep; 25(9):471-6. PubMed ID: 15324739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iNKT cells in microbial immunity: recognition of microbial glycolipids.
    Kinjo Y; Ueno K
    Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
    Papoutselis M; Spanoudakis E
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):358-365. PubMed ID: 32234294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.
    Veerapen N; Kharkwal SS; Jervis P; Bhowruth V; Besra AK; North SJ; Haslam SM; Dell A; Hobrath J; Quaid PJ; Moynihan PJ; Cox LR; Kharkwal H; Zauderer M; Besra GS; Porcelli SA
    Bioconjug Chem; 2018 Sep; 29(9):3161-3173. PubMed ID: 30085659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.